Serous Cavity Fluid and Cerebrospinal Fluid Cytopathology [electronic resource] /
Ali, Syed Z.author.
Cibas, Edmund S.author.
Cytologic diagnosis by examination of exfoliated cells in serous cavity fluids is one of the most challenging areas in clinical cytopathology. Almost 20% of the effusions examined are directly or indirectly related to the presence of malignant disease, with carcinoma of the lung as the most common underlying culprit.  This volume published in the Essentials in Cytopathology book series will fulfill the need for an easy-to-use and authoritative synopsis of site specific topics in cytopathology. .
Description based upon print version of record.
Serous Cavity Fluidand Cerebrospinal FluidCytopathology; Foreword; Series Preface; Contents; 1: Introduction, Clinical and Technical Aspects; Background; Malignant Pleural Effusion - Pathogenesis; Malignant Neoplasms in Serous Cavity Fluids; Malignant Pleural Effusion - Prognosis; Technical Aspects; Ancillary Techniques for the Diagnosis of Serous Cavity Fluids; Cytochemical Stains; Immunoperoxidase (IPOX) Stains; Diagnostic Profile; Major Diagnostic Issues in Cytologic Interpretation of Serous Cavity Fluids; Selected Reading; 2: Normal Cytology
Major Cell Types Commonly Seen in SCFs (Figs.  2.1 and 2.2)Histiocytes (Figs. 2.3 and 2.4); Lymphomononuclear Cells; Mesothelial Cells (Figs.  2.5 , 2.6 and 2.7); 3: Reactive Mesothelial Hyperplasia; Clinico -Cytopathologic Characteristics (Figs.  3.1 , 3.2 , 3.3 , 3.4 , 3.5 , 3.6 , 3.7 , 3.8 , 3.9 , 3.10 , 3.11 and 3.12); Reactive Mesothelial Hyperplasia vs. Malignant Mesothelioma; Major Underlying Causes of Mesothelial Proliferation; p53 Immunostaining in Mesothelial Hyperplasia vs. Cancer; GLUT-1 Immunostaining in Mesothelial Hyperplasia vs. Cancer; Selected Reading
4: Malignant MesotheliomaEtiologic Factors; Clinico-Radiologic Features; Therapeutic Approach and Prognostic Outcomes; Malignant Mesothelioma (Epithelioid type) (Figs.  4.1 , 4.2 , 4.3 , 4.4 , 4.5 , 4.6 , 4.7 , 4.8 , 4.9 , 4.10 , 4.11 , 4.12 , 4.13 , 4.14 , 4.15 , 4.16 , 4.17 , 4.18 , 4.19 , 4.20 , 4.21 , 4.22 and 4.23); Malignant Mesothelioma - Other Cytomorphologic Features; Malignant Mesothelioma vs. Adenocarcinoma; Malignant Mesothelioma (Epithelioid type) - Differential Diagnosis; Types of Mucins and Staining Results (Figs.  4.24 and 4.25)
Combined E-Cadherin and Calretinin ImmunostainingOther Mesothelioma Markers; CK 5/6; D2-40; WT-1; Role of CK 7 and CK 20; Mesothelioma vs. Adenocarcinoma - Johns Hopkins Cytopathology Lab Immunopanel; Cytogenetic Analysis of Effusions from Malignant Mesothelioma; FISH Analysis of Effusions from Malignant Mesothelioma; Selected Reading; 5: Metastatic Cancers; Adenocarcinoma (Figs.  5.1 , 5.2 , 5.3 , 5.4 , 5.5 , 5.6 , 5.7 , 5.8 , 5.9 , 5.10 , 5.11 , 5.12 , 5.13 , 5.14 , 5.15 , 5.16 , 5.17 , 5.18 , 5.19 , 5.20 , 5.21 , 5.22 , 5.23 and 5.24); Adenocarcinoma - Differential Diagnosis
Squamous Cell Carcinoma (Figs.  5.25 , 5.26 and 5.27)
Includes bibliographical references and index.
Cytologic diagnosis by examination of exfoliated cells in serous cavity fluids is one of the most challenging areas in clinical cytopathology. Almost 20% of the effusions examined are directly or indirectly related to the presence of malignant disease, with carcinoma of the lung as the most common underlying culprit.  This volume published in the Essentials in Cytopathology book series will fulfill the need for an easy-to-use and authoritative synopsis of site specific topics in cytopathology. .
Pathology.
Pathology.
Essentials in Cytopathology